On the other hand, differential signatures of S100 protein expressions in HCC sample biopsies might also be indicative of bad prognosis, the presence of specific mutations or recurrence after surgery, as suggested by serum levels of S100A9 and S100P [166,167]. This evidence concerns the gene S100A1 and hepatocellular carcinoma.